Log In
Print
BCIQ
Print
Print this Print this
 

CRLX101 (formerly IT-101)

  Manage Alerts
Collapse Summary General Information
Company Arrowhead Research Corp.
DescriptionDual inhibitor of topoisomerase I (TOP1) and hypoxia-inducible factor 1 alpha (HIF1A; HIF1-alpha)
Molecular Target Topoisomerase I (TOP1) ; Hypoxia-inducible factor 1 alpha (HIF1A) (HIF1-alpha)
Mechanism of ActionTopoisomerase I inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$53.2M

$2.4M

$32.8M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today